StockData
Evaxion A/S logo

Evaxion A/S (EVAX) KPIs and segments

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.77+0.03 (+1.09%)

Close on Nov 16, 2026Market cap $23.10MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Evaxion A/S's business

Coming soon

This tab will track the numbers specific to Evaxion A/S's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?